Best Sano Genetics Podcasts (2024)

1
EP 135: Integration of newborn sequencing programs into healthcare systems with Dr. Ingrid Holm 41:16

31m ago41:16

41:16

0:00 Introduction 1:30 Ingrid’s initial interests in genetics, paediatrics, and newborn screening 2:45 How the original BabySeq project, a pioneering newborn sequencing program got started, how it’s going, and the launch of BabySeq2 8:45 Lessons from BabySeq1 and goals for BabySeq2 10:30 Potential societal and long-term considerations for those inv…

1
#350 Large Language Models are transforming healthcare with Dr Keith Grimes from Curistica 1:49:37

5h ago1:49:37

1:49:37

This week James is joined by Dr Keith Grimes, a Digital Health Specialist, Clinical Product Manager, and experienced General Practitioner with over 25 years of experience in primary care and medical leadership. Utilising his passion for AI and Digital Health technology, Keith has successfully led clinicians and product teams to deliver world-class …

1
EP 134: Prenatal genetic testing and the future of AI in genetic counselling with Kira Dineen, host of DNA Today 40:44

30m ago40:44

40:44

0:00 Introduction 1:00 The backstory of how Kira first started DNA Today in 2012, when she was still in high school! 3:30 Some of Kira’s favourite topics she has discussed on DNA Today, including the legacy of Henrietta Lacks, and the story of a Glee actress with down syndrome 10:00 Kira’s best practices for podcasting, from over 10 years of experi…

1
#349 The Reproductive Revolution with Dr Helen O'Neill, CEO of Hertility [The Healthtech Podcast LIVE] 57:25

3h ago57:25

57:25

This week, we're revisiting our very first Healthtech Podcast Live event where James was joined by Dr Helen O'Neill Founder and CEO of Hertility. As a lecturer in reproductive and molecular genetics and a leading expert in reproductive science, Helen founded Hertility with the goal to bring reproductive science out of the lab and into the hands of …

1
EP 133: Insights into pharmacogenomics and increasing diversity in genomics research with Dr. Emma Magavern 39:17

8d ago39:17

39:17

0:00 Introduction 2:00 The value of an English Literature degree in designing and analysing research studies in medicine 3:45 Emma’s entrance to pharmacogenomics and her transition from practising physician to genetics research 6:00 How the East London Genes and Health program is increasing representation of diverse populations, namely South Asians…

1
#348 How a tech bio community can accelerate AI/ML adoption with Dr. Raminderpal Singh, CEO of Incubate Bio 1:13:11

4d ago1:13:11

1:13:11

This week, James is joined by Dr. Raminderpal Singh, CEO of Incubate Bio and leading advocate for HitchhikersAI.org. With over 30 years of experience in the US and Europe, Raminderpal has excelled in both the semiconductor and healthcare industries. As CEO of Incubate Bio, Raminderpal is dedicated to revolutionising drug discovery through advanced …

1
EP 132: From mammoths to genome editing, trailblazing genetics with Dr. George Church 47:41

16d ago47:41

47:41

0:00 Introduction 1:00 George’s upcoming big projects, including developing full recycling, renewing energy, creating bioweather maps, and harnessing citizen science 6:45 Progress in engineering viral resistance in humans, including thoughts from pre- and post- pandemic 11:00 A swapped genetic code that prevents viral infections and gene transfer b…

1
#347 The link between wellness and behavioural science with Dr. Jennifer Huberty, Founder and Chief Science Officer at Fit Minded Inc 1:09:02

13d ago1:09:02

1:09:02

This week, James is joined by Dr. Jennifer Huberty, a leader in the digital health space with over two decades of experience shaping the intersection of science and wellness. Once at the helm of science at Calm, she's now the driving force behind Fit Minded Inc, guiding digital health companies with her unique blend of academic insight and industry…

1
EP 131: The potential of somatic genomics in drug discovery and development with Jake Rubens 44:57

18d ago44:57

44:57

0:00 Intro 0:40 Jake’s experiences as a serial entrepreneur starting five companies with a basis in genomic science 5:30 Opportunities for research and drug development in the realm of somatic science 9:20 Somatic evolution and how it provides valuable insights into disease mechanisms 12:30 Advantages and disadvantages of studying germline genome-w…

1
#346 How technology can connect communities: a vision for ageing and care with Max Parmentier, CEO of Birdie 1:06:34

19d ago1:06:34

1:06:34

This week, James is joined by Max Parmentier, CEO and co-founder of Birdie, the intelligent platform for home care. Founded in 2017, Birdie now equips over 1,000 homecare providers with digital tools for managing, delivering and championing outstanding care. Previously, Max founded and grew a global e-marketplace spin-off from the Global Fund to fi…

1
EP 130: Quarterly insights into noncoding variants and GWAS with Dr. Veera Rajagopal 51:56

25d ago51:56

51:56

Show Notes: 0:00 Introduction 1:20 How polydactyl mutations can inform research on non-coding variant mechanisms The importance of low-affinity binding between transcription factors and targets How these lessons can help us improve our understanding of drug and target discovery See Veera’s January round-up for more information: https://www.gwasstor…

1
#345 The importance of Health Economics with Dr Hugh Harvey, MD at Hardian Health 55:52

27d ago55:52

55:52

This week, James is joined by Dr. Hugh, whose career spans over a decade, transitioning from a former Consultant Radiologist within the NHS to his current role as the Managing Director of Hardian Health. Hardian Health is a consultancy specialising in Software as a Medical Device, offering support to startups in the healthcare sector. Their service…

1
EP 129: Patient advocacy for genetic ALS and FTD with Jean Swidler, Executive Director of End the Legacy 38:44

1M ago38:44

38:44

0:00 Introduction 0:45 Jean’s personal experiences with family members with genetic ALS 10:00 Jean’s thoughts on the barriers and facilitators to providing treatment for those with genetic ALS 13:20 Insights into C9orf72, a common genetic determinant of ALS, and how it can also be associated with FTD 16:10 Jean’s experiences as an active advocate f…

1
#344 Why we need more women in Pharma, with Aline Gegout from Roche 1:03:45

1M ago1:03:45

1:03:45

This week, James is joined by Dr Aline Gégout, Global Head of Operations and Quality at Roche Diabetes Care. After starting with the company in 2009, she has held multiple leadership positions, including leader of a chemical production site, matrix leader in a global environment for different business units, and as Head of Operations in a diagnosti…

1
EP 128: Parkinson’s disease and precision medicine with Drs. James Beck and Ignacio Mata 50:18

2M ago50:18

50:18

0:00 Introduction 1:05 Insights into the PD GENEration’s (a programme from the Parkinson's Foundation) milestones and progress points for the upcoming year 3:30 The shifting attitudes and perspectives of neurologists and healthcare workers at the PD GENEration 5:50 Insights into Nacho’s work with the genetics of Parkinson’s disease 10:20 Barriers a…

1
#343 Breaking into healthtech without a health background, with Caitlin Baltzer, CEO of MYndspan 15:23

2M ago15:23

15:23

We take a look back at episode 286, when James welcomed Caitlin Baltzer, CEO of MYndspan. In this clip, Caitlin shares her unconventional journey in the healthtech industry and highlights the importance of a passion for knowledge to achieve success in a new industry. Apply to be a guest: www.thehealthtechpodcast.com Subscribe to Healthtech Pigeon 🐦…

1
EP 127: Insights into precision medicine, fatty liver disease, and minimally invasive diagnostic tools with Dr. Mazen Noureddin 39:10

2M ago39:10

39:10

0:00 Intro 0:25 Mazen’s lifelong commitment to furthering the field of precision medicine in liver disease research, fueled by a personal connection of his grandmother developing MASH cirrhosis 2:30 Breakthroughs in the field of metabolic dysfunction-associated steatotic liver disease (MASLD) since the beginning of Mazen’s career 5:30 The potential…

1
#342 Everything you need to know about genome sequencing, with Patrick Short from Sano Genetics 51:11

2M ago51:11

51:11

This week, James is joined by Patrick Short, co-founder and CEO of Sano Genetics. Sano Genetics are accelerating the world's transition to personalised medicine by revolutionising the medical research participant journey with engaging digital experiences, easy-at-home testing, and a privacy-first approach. Their platform allows researchers to condu…

1
EP 126: Patient-led research for ultra-rare disease drug development with Julia Taravella, Executive Director of Rare Trait Hope Fund 39:41

2M ago39:41

39:41

0:00 Introduction 0:25 Julia’s personal experience with ultra-rare diseases within her family 10:25 The importance of increasing accessibility to genetic testing across populations to learn more about ultra-rare diseases 14:00 The origin story of Rare Trait Hope Fund 23:50 Current research and next steps in developing potential gene therapies for a…

1
#341 Are holograms the future of surgery? With Alison Sundset, CEO of Holocare 1:12:06

2M ago1:12:06

1:12:06

This week, James is joined by Alison Sundset, CEO of HoloCare, a Norwegian healthtech startup developing mixed reality technology to help clinicians plan complex operations more effectively. Alison has over 30 years of experience in the pharmaceutical, biotechnology, and clinical laboratory industries, and has built a track record of transforming p…

1
EP 125: The future of UK Clinical Trial Policy: Innovation, integration, and game-changing legislation with Lord James O’Shaughnessy 45:23

2M ago45:23

45:23

0:00 Introduction 1:25 How Lord O’Shaughnessy became involved in scientific policy making and his path to writing the UK Commercial Clinical Trials Review. 04:05 How Lord O’Shaughnessy pivoted from education to a focus on life sciences 06:38 The biggest challenges Lord O’Shaughnessy faced during his time as Parliamentary Under Secretary for Health …

1
#340 What is a Chief Medical Officer? And how do I become/hire one? With Benjamin Viaris De Lesegno 1:09:57

2M ago1:09:57

1:09:57

This week, James is joined by Benjamin Viaris De Lesegno, NHS consultant, humanitarian doctor, and co-founder of Leva Clinic. Leva Clinic is the first CQC registered online clinic for patients with chronic pain. Apply to be a guest: www.thehealthtechpodcast.com Subscribe to Healthtech Pigeon 🐦: www.healthtechpigeon.com Get in touch with James: www.…

1
EP 124: How ReCode Therapeutics is pioneering tissue specific delivery of gene therapies for Primary Ciliary Dyskinesia with John Matthews 42:00

2M ago42:00

42:00

0:00 Introduction 01:10 How growing up in Malawi planted the seeds for John’s career in medicine and transition to therapeutic development 04:35 Why John focuses on rare diseases and conditions such as asthma 06:01 What has changed over the last decade in terms of treating and understanding asthma and the progress that genetics has enabled 07:31 Wh…

1
EP 123: The ethics of newborn genome screening: Actionable insights and beyond with Holly Peay, Senior Research Scientist at the Research Triangle Institute 45:34

2M ago45:34

45:34

0:00 Introduction 0:50 Holly’s background and career so far 03:30 Complex decision-making and multiple risk factors: Family history, genetics, phenotypes and beyond 07:05 Changes within the last decade to help people make complex, sometimes subjective, healthcare decisions 09:20 Impact on people: The RTI’s mission and the Early Check Study 13:45 Ne…

1
#339 Working in healthcare is a privilege, with Francesca Wuttke CEO of nen 1:16:53

3M ago1:16:53

1:16:53

Francesca Wuttke is the founder and CEO of nen, a digital health company founded to help children with cancer, their families, and HCPs with pain management. nen offers a novel mission-driven approach to address pain management through play, leveraging gamification approaches and CBT to modulate pain and improve overall wellbeing. https://www.nen.h…

1
EP 122: Building genome-scale engineered cells for biotechnology with Leslie Mitchell, Co-founder and CEO of Neochromosome 35:55

3M ago35:55

35:55

Summary: 0:00 Introduction 01:01 How Leslie got into the field of synthetic biology and engineering, and her career journey so far 02:45 What Leslie accomplished during her postdoc and recent transformations in the field of genomics 05:57 The impacts of non-coding regions of the genome and the outcome of deletions 08:20 How long it takes to make ch…

1
#338 How do you start a biotech company from nothing? With Vishal Doshi from AUM Biosciences 18:43

3M ago18:43

18:43

We take a look back at episode 270, when James welcomed Vishal Doshi, Founder of AUM Biosciences. In this clip, Vishal shares his experiences as a first-time entrepreneur in the biotech industry, and why he prioritised understanding points of failure in his business plan over points of success. Apply to be a guest: www.thehealthtechpodcast.com Grab…

1
#337 The Power of Purpose, Vision, and Identity in Challenging Times with Emil Hewage from BIOS 20:38

3M ago20:38

20:38

We take a look back at episode 307, when James welcomed Emil Hewage, CEO of BIOS Health. In this clip, Emil and James share their insights into leading a team through challenges, the importance of purpose and vision, and the need for entrepreneurs to find their focal point. Apply to be a guest: www.thehealthtechpodcast.com Grab a ticket for The Hea…

1
EP 121: Breakthroughs and insights in ALS research with Dr. Michael Benatar 44:10

3M ago44:10

44:10

Summary: 0:00 Introduction 0:50 Reflections from the 34th International Symposium on ALS/MND in Basel 1:50 Michael’s professional journey, initial challenges he encountered, and how the field of neurology has evolved over the years 3:10 An introduction to the ALS landscape, including its presentation, the genes involved, and potential treatment opt…

1
EP 120: Exploring the frontiers of gene therapy and AAVs with Dr. Nicole Paulk, CEO and Founder of Siren Biotechnology 43:47

3M ago43:47

43:47

0:00 Introduction to Dr. Nicole Paulk, a pioneer in AAV research and the founder of Siren Biotechnology 0:50 The moments that shaped Nicole’s career path and her passion for gene therapy and AAV research 9:20 Nicole’s academic research career and her transition from academia to the biotech industry 23:00 The story behind the founding of Siren Biote…

1
#336 When does AI become human? With Dr Dom Pimenta 1:07:25

4M ago1:07:25

1:07:25

This week, James is joined by Dr. Dom Pimenta, CEO of TORTUS, a generative AI startup building a next generation assistant for doctors. https://tortus.ai Dom is a UK-trained and practicing physician, and an AI healthcare academic with 16 years of clinical experience. He co-founded TORTUS in the LD19 cohort of Entrepreneur First. Apply to be a guest…

1
#335 Turning a parent's worst nightmare into impact and joy, with Dom Raban from Xploro 25:41

4M ago25:41

25:41

We take a look back at episode 311, where James welcome Dom Raban, co-founder and CEO of Xploro. In this clip, Dom and James share their insights on gamification as a means to education, moving the adoption frontier forwards, and the importance of addressing fundamental needs before developing complex technology, with the simplest solutions sometim…

1
EP 119: Revolutionising drug discovery: how the Pharma Proteomics Project is combining genetic and proteomic data with Chris Whelan 38:25

3M ago38:25

38:25

0:00 Introduction 01:00 Chris’ background and career to date 02:10 What is the Enigma Project? 04:48 How is genetics being applied to drug discovery today and how does proteomics fit in? 09:23 When the UKBiobank Pharma Proteomics Project began and how long it took to set up 10:57 54k UK Biobank participants tested - discussion of findings 14:33 The…

1
EP 118: The role of genetics in drug discovery and development with Dr. Matt Nelson 42:56

4M ago42:56

42:56

Summary: 0:00 Introduction 5:45 Lessons learned from 15 years at GSK: How has genetics and drug discovery evolved over time? 8:10 Matt’s seminal 2015 paper: Quantifying the impact of human genetic evidence on the probability of success in drug development 11:40 Which types of genetic evidence are the best drivers of success in clinical trials? 13:3…

Podcasts Worth a Listen

Sano Genetics Podcasts

Podcasts Worth a Listen

Quick Reference Guide